|
©Copyright November,
2000 Marketdata Enterprises, Inc. Reproduction or distribution in whole or in
part, by any means written or electronic, without prior written permission of
the copyright owner is strictly prohibited. Violators will be fully prosecuted
under US copyright laws
Smoking
Cessation Products & Services: A Market Analysis
(November 2000)
Table of Contents
Page
Introduction:
Report Scope, Sources, Methodology
* Discussion of study scope, evolution of the market, mkt.
Segments defined,
availability of information/statistics, list of government
& private sector sources
used. 1-7
Overview of Major
Findings
* Discussion of healthcare and others costs of smoking.
Description and definition
of the mkt., its nature and segments. Summary of smoker
demographics, major quit methods used and success rates. Regulatory trends.
Status report of employer smoking cessation programs, involvement via
non-profit/commercial organizations. Overview of role of the major commercial
and non-profit smoking cessation providers. Market size, growth, forecasts from
1993-2004. Summaries/$ values of nicotine patches, gum, nasal sprays, inhalers,
pharmacotherapy markets. Highlights of all chapters. 8-33
Physical &
Psychological Motivations To Quit: Success Rates
* Discussion of components of the quitting process/steps,
causes for relapse, psychological factors, why behavior modification combined
with other methods boosts quit rates, typical success rates by type
method-results of meta-analyses and recent research, ranking of quit rates by
type, withdrawal symptoms, weight gain. 34-39
The Demographics
of Smoking: Who, How Many?
40-55
* Summary & discussion of national smoking prevalence
among the population,
related healthcare
costs, smoking rates by males/females/race – 1997.
* The cost to American employers: productivity, medical
costs, other.
* Per capital consumption of cigarettes.
* Percent of population that are smokers, by: sex, age,
race, education, income
* Discussion of trends in adolescent smoking rates.
* Results of Prevention Magazine’s Prevention Index.
* Public attitudes toward smokers.
Tables:
- Risk behavior trends: risk behaviors that worsened:
1991-97, smoking vs. others
- Cigarette consumption in the U.S., 1900-1999 (no. of
cigarettes, per capita)
- Current cigarette smoking in persons age 18+, by sex,
1965-1997
- Number of adults who were current smokers, by sex, race,
age: 1965-1997
- Percentage of adults who were current smokers, by sex,
race, age: 1965-1997
Tables, continued… Page
- Age adjusted prevalence (%) of current smokers, by sex,
race, education: 1974-1995
- Percentage of young adults who were current, former, or
never smokers, by sex, race,
education:
1965-1995
- Current cigarette smoking prevalence (%) among adults aged
18+, by state: 1984-1998
- Total U.S. cigarette advertising & promotional
spending: 1975-1997
Federal, State
& Local Anti-Smoking Regulatory Environment
* Discussion of effects of 1964 Surgeon General’s Report,
failure to meet goals
of Healthy People 2000, new targets for Healthy People 2010,
role of FDA to oversee
the tobacco industry, 1998 tobacco industry settlement with
states-key provisions, current approach by government toward tobacco control
(educational, regulatory, economic interventions). 56-64
The Major Anti-Smoking Organizations
Profiles/descriptions of some major anti-smoking groups
(address, strategies, goals):
- Action on Smoking and Health (ASH)
- Foundation for a Smokefree America
- INFACT
- STAT (Stop Teenage Addiction to Tobacco)
- The American Legacy Foundation
Corporate
Smoking Cessation Efforts & Programs: A Status Report 65-74
* Overview, discussion of
environmental tobacco smoke.
* Economic consequences of smoking:
absenteeism, lost productivity, building
maintenance, medical costs, etc.
* Corporate smoking restrictions:
dramatic rise in company restrictions since 1987,
methods used by corporations and usage of outside “vendors” (for-profit,
non-profit),
role of EAP programs.
* Government’s activities at
state/federal levels.
* Major findings of 1992 National
Survey of Worksite Health Promotion Activities:
discussion of this landmark report by the ODPHP, its value.
Tables:
*
Percent of private worksites (50 employees or more), by year of initial
health promotion activities – 1992.
* Percent of private worksites (50
empl. or more), who use outside companies to provide health promotion services,
by size – 1992.
* Percent of private worksites (50
empl. or more), that have a smoking policy and offer info. or activities
concerning smoking, by size – 1992.
* Prevention and health promotion in
HMOs, by % of enrollees, by type
activity – 1992 (smoking cessation vs. 13 other activities/programs).* Percent
of worksites offering health promo. Info. or activities, by subject – 1985
& 1992.
|
Page
Commercial
Smoking Cessation Programs
In-depth profiles of the major
commercial programs: address, activities, major
customers served, estimated 1999
revenue/people served, cost of their programs,
history and evolution of the firm
since early 1990s). 75-82
* Addiction Management Systems
* Smoke Stoppers
* SmokEnders International
* Smokeless
Non-Profit Organization Smoking Cessation Programs 83-91
In-depth profiles of the major
non-profit programs: address, activities, major
customers served, estimated
revenue/people served, cost of their programs, history
and evolution of the firm since early
1990s).
* American Cancer Society
* American Lung Association
* American Heart Association
* General Conference of 7th Day
Adventists
The
Role of MDs and Pharmacists in Smoking Cessation
92-96
* Discussion of why MD involvement is
so important, updated Public Health
Service/Government clinical practice guidelines regarding patient
interventions,
obstacles to greater MD involvement.
* Physician involvement: Doctors Ought
to Care (DOC), its role/goals.
* Medications used for smoking
control: discussion of drugs used or in testing stage
(Buspar, Clonidine, Prozac, Nortriptyline, Zyban, nicotine patches).
* Role of pharmacists: why they are
among most trusted by consumers, major groups.
Role
of The Internet in Smoking Cessation 97-101
* Overview and history of the internet
as a tool for information dissemination and
counseling, creation of SCARC (Smoking Control Advocacy Resource Center)
and its
activities.
* Discussion/names of major Web-based
smoking cessation sites: WebMD, Mediconsult,
Dr.koop.com, Medscape, About.com, effect of computer-tailored self-help
on quit rates.
* Prominent smoking cessation
websites/organizations of the Web (DOC, Nicotine
Anonymous, Americans for Non-Smokers Rights, QuitNet, others).
* Profiles/activities of: Nicotine
Anonymous, QuitNet.
Page
Market
Size, Growth and Segments 102-24
* Summary & overview of the
market: major developments of past 5-7 years, down-
sizing and restructuring of the major commercial smoking cessation
providers.
* Definition/list of the major market
segments (1. nicotine replacement therapy products:
gum, patches, nasal sprays, inhalers, 2. commercial cessation programs,
3. non-profit
cessation programs, 4.
medications).
* Estimated number of users of each
product/method: 1993 & 1999.
* U.S. $ market potential estimates:
trends and mkt. Changes/growth since 1993, Rx to
OTC conversions of nicotine patches, major trends.
Tables:
-
Estimated $ value of smoking cessation market: 1992-2000.
- Estimated $ value of market, by
product/service segment: 1992, 1998, 1999, 2000, 2004F
The Nicotine Replacement Therapy Market
(nicotine patches,
nicotine gum, nasal sprays, inhalers)
* Overview of consolidation in the drug industry, pending
merger of Glaxo Wellcome
and SmithKline
Beecham and effect on smoking cessation products mkt.
* Concept of nicotine replacement therapy; discussion.
The Nicotine Patch Market: history and nature of the product,
4 brands currently of the
market (Nicotrol, Nicoderm, Prostep, Habitrol),
discussion of: administration
(how used, dosages, duration), side effects, efficacy
(quit rates, results of
meta-analyses), market developments, conversion of
3 brands from Rx to OTC
status, name/address of the brands' manufacturers. 113
The Nicotine Gum Market: History & nature of the product (Nicorette),
1998 & 1999
sales, user cost per day, administration, efficacy/quit rates,
side
effects/complications, usage in combination with
counseling, name/address of
the brands' manufacturer. 116
The Nicotine Nasal Spray Market: history & nature
of the products, cost per day, side effects,
efficacy/quit rates, name/address
of the brands' manufacturer. 120
The Nicotine Inhaler Market: history & nature of
the products, cost per day, side effects,
efficacy/quit rates, name/address of
the brands’ manufacturer. 122
Table:
-
Meta-Analysis of efficacy of various nicotine replacement
therapy products
Page
The
Pharmacotherapy (drugs) Market
* Zyban: history
& nature of the product, 1998-1999 sales, cost per day for users,
side effects,
efficacy/quit rates, name/address of the brands’ manufacturer.
* Clonidine:
history & nature of the product, side effects, efficacy/quit rates,
name/address of
the brands’ manufacturer.
* Nortriptyline:
history & nature of the product, side effects, efficacy/quit rates,
name/address of
the brands’ manufacturer. 125-130
Reference
Directory of Industry Sources
* Names/address/phones/websites of the leading commercial
and non-profit smoking
cessation program providers, government agencies,
consultants, health promotion organizations. 131-133
|